Riegel Loophole Keeps PMA Device Cases Afloat, Barely

Law360, New York (July 17, 2013, 9:40 PM EDT) -- The U.S. Supreme Court ruled five years ago that federal law preempts most allegations targeting medical devices that have received pre-market approval. Medical device makers now face fewer lawsuits because of the ruling, as was expected, but plaintiffs have exploited a loophole in the decision to sustain a small category of claims over the products.

The court held in Riegel v. Medtronic in February 2008 that plaintiffs cannot challenge under state law the safety or effectiveness of a device preapproved by the U.S. Food and Drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.